Form 4: Rhythm Pharmaceuticals Director Lynn A. Tetrault Executes Stock Option and Sells Shares

Director Lynn A. Tetrault exercised stock options and sold shares of Rhythm Pharmaceuticals, Inc. on August 12, 2024, according to a Form 4 filing with the SEC.

Summary

• On August 12, 2024, Lynn A. Tetrault, a director of Rhythm Pharmaceuticals, Inc., exercised stock options to acquire 10,000 shares of common stock at a price of $4.15 per share.
• Following the exercise of the options, Tetrault sold 9,593 shares at a weighted average price of $44.6154, with prices ranging from $44.32 to $45.19.
• Additionally, Tetrault sold 407 shares at a weighted average price of $45.3717, with prices ranging from $45.35 to $45.61.
• After these transactions, Tetrault directly owns 3,000 shares of Rhythm Pharmaceuticals common stock.
• Tetrault also directly owns options for 10,000 shares of Rhythm Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The sales could be for personal financial planning and not necessarily indicative of a negative outlook on the company.

Industry Context

This filing reflects insider trading activity, which is closely monitored by investors for insights into management's perspective on the company's prospects. It is important to consider this activity in the context of the company's overall performance and industry trends.

Stakeholder Impact

• Shareholders may interpret the stock sales as a lack of confidence, although the transactions were conducted under a pre-arranged trading plan.

Key Dates